Musa, Mary Jane .
HRN: 27-86-73 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2025
AMPICILLIN 1GM (VIAL)
11/22/2025
11/24/2025
IV
2 G
Every 6 Hours
Leaking BOW
Checking Initial Appropriateness
11/23/2025
CO-AMOXICLAV 625MG (TAB)
11/23/2025
11/30/2025
ORAL
625mg
BID
S/P NSD With Repair
Checking Initial Appropriateness